Bathocuproine-Based Peptide Quantitation Assay

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining peptide concentrations, such as UV absorption and BCA assays, are insensitive, consume large sample volumes, and lack reproducibility, making them unsuitable for precise analysis in mass spectrometry.

Innovation Solution

A direct peptide or protein concentration method using a reagent composition that forms a colored complex with a specific formula, measured at 450 nm to 500 nm, allowing for accurate quantitation with reduced sample volume and improved sensitivity, utilizing bathocuproinedisulfonic acid disodium salt hydrate and copper sulfate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If UV absorption or BCA assays are used to determine peptide concentration, then the method is commercially available and relatively simple to perform, but the sensitivity is insufficient and sample volume consumption is excessive

Engineering Contradiction:
Improvepeptide concentration detection sensitivityVSAvoidsample volume consumption
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent changes the detection parameters by using a different chemical reaction system (copper chelation with bathocuproine disulfonate) that operates at alkaline pH and produces a highly sensitive colorimetric signal. This parameter change enables detection with much lower sample volumes while achieving the required sensitivity for peptide quantification

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces copper ions and bathocuproine disulfonate as intermediary substances that mediate the detection process. The copper-peptide complex formation followed by bathocuproine chelation creates a highly sensitive detection system that requires minimal sample volume while providing accurate concentration measurements

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If current protein quantitation methods are used, then the procedures are established and commercially available, but they lack reproducibility and sample characterization capability

Engineering Contradiction:
Improveexperiment reproducibilityVSAvoidsample characterization complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent performs preliminary sample characterization through copper chelation analysis before mass spectrometry experiments. This preliminary action provides normalization data that improves reproducibility of subsequent MS experiments, establishing a standardized workflow that can be consistently applied across different samples and experiments

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If biuret or Lowry methods are used, then protein quantitation can be performed, but the sensitivity is insufficient and interference from common reagents occurs

Engineering Contradiction:
Improvepeptide concentration detection limitVSAvoidinterference from detergents and reagents
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the detection chemistry to use copper chelation with bathocuproine disulfonate at alkaline pH, which has different selectivity characteristics compared to biuret or Lowry methods. This parameter change reduces interference from common reagents like detergents while enhancing sensitivity for peptide detection

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the alkaline conditions that might be considered harsh into a benefit, as the alkaline pH environment enhances the copper-chelate colorimetric reaction sensitivity and selectivity, while being compatible with many peptide samples and reducing interference from certain reagents

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides enhanced sensitivity and reduced variability, enabling robust signal detection with a high signal-to-noise ratio, allowing for precise quantitation of peptides in small volumes, suitable for mass spectrometry analysis.

Implementation Method 1

combining the sample with a quantitation assay reagent composition comprising a complex to form a mixture where the complex comprises the following general formula... measuring absorbance of the colored complex at 450 nm to 500 nm

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

measuring absorbance of the colored complex at 450 nm to 500 nm as a direct indicator of peptide or protein concentration

Methodology Applied
Scientific EffectAbsorption Spectroscopy: Absorption Spectroscopy

Data Source

PatentUS11821902B2Quantitative peptide or protein assay
Publication Date: 2023.11.21 LIFE TECHNOLOGIES CORP
  • US11821902B2 patent drawing
  • US11821902B2 patent drawing
  • US11821902B2 patent drawing

AI summary

Peptide and/or protein quantitation methods, kits, and compositions, particularly useful for mass spectrometry, are provided herein based on a bathocuproine-based composition complex such as bathocuproinedisulfonic acid disodium salt hydrate complex. The methods are one-step rapid absorbance methods using small sample volumes. They produce a robust signal with high signal to background ratio and accurately quantitate even complex peptide mixtures with low variability and high sensitivity.